Nafdac Pharmacovigilance/Post-Marketing Newsletter

Pharmacovigilance/Post-Marketing Newsletter, 2014 Vol 7 No 2

Editor’s Note: We wish to thank all our numerous stakeholders who have been working tirelessly with the National Pharmacovigilance Centre (NPC) to ensure the safe use of medicines in Nigeria. The NPC is committed to sending out quarterly newsletter to its stakeholders. The objectives of the Newsletter are to disseminate information on Pharmacovigilance activities nationally and globally, to educate stakeholders on medicine safety issues, to promote rational use of drugs and to promote spontaneous reporting. This second quarter newsletter focuses on Antibiotic Resistance and Pharmacovigilance. We encourage Health care Professionals and other stakeholders to continue to report all adverse drug reactions. Your valued comments and acknowledgement of receipt of this issue through our email addresses ( This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it. ) would be most appreciated. Click for more...

pharmacovigilance/post-marketing newsletter, 2014 Vol 7 No 1

Editor’s Note: We wish to thank all our numerous stakeholders who have been working tirelessly with the National Pharmacovigilance Centre (NPC) to ensure the safe use of medicines in Nigeria. The NPC is committed to sending out quarterly newsletter to its stakeholders. The objectives of the Newsletter are to disseminate information on Pharmacovigilance activities nationally and globally, to educate stakeholders on medicine safety issues, to promote rational use of drugs and to promote spontaneous reporting. This first quarter newsletter focuses on Pharmacovigilance of anti-tuberculosis drugs. Other features in this edition include compilation of adverse reactions as documented in Reactions’ Weekly. Click for more...

pharmacovigilance/post-marketing newsletter, 2013 Vol 6 No 2

We wish to thank all our numerous stakeholders who have been working tirelessly with the National Pharmacovigilance Centre (NPC) to ensure the safety of medicines in Nigeria. The NPC is committed to sending out quarterly newsletter to its stakeholders. The objectives of the Newsletter are to disseminate information on Pharmacovigilance activities nationally and globally, to educate stakeholders on drug safety issues, to promote rational use of drugs and to promote spontaneous reporting. This second quarter newsletter focuses on Adverse Events Following Immunization (AEFIs) received during the first phase implementation of MenAfriVac Vaccines in five States in the North (Zamfara, Gombe, Jigawa, Katsina and Bauch) in 2011. Click for more...

ONLINE PORTALS

napams

Contact Us from Mon - Friday: 08:00-16:00 GMT+1

Write Us:

NAFDAC Corporate Headquarters,

Plot 2032, Olusegun, Obasanjo Way,

Zone 7, Wuse, Abuja, Nigeria

 

Lagos Operation Office:

Plot 1, Industrial Estate, Lagos- Oshodi Apapa Express Way, Isolo, Lagos, Nigeria

 

 

 

 

 

 

For Enquiries:

Call: +234(0)-1-4609750

Email:nafdac@nafdac.gov.ng

 

 

 

 

 

 

 

 

 

 

 

For Complaints:

Call: +234(0)909-763-0506

         +234(0)909-763-0507

Email:reforms@nafdac.gov.ng

Or Send Us a Complaint

 

 

 

 

 

 

 

 

 

Contact Other NAFDAC Offices Nationwide